摘要
目的了解员工暴露前接种人用狂犬病疫苗后的免疫效果,并对比使用两种不同试剂盒检测抗体阳转率是否存在差异。方法采集员工接种人用狂犬病疫苗(地鼠肾细胞)以及冻干人用狂犬病疫苗(Vero细胞)共计172例,分别使用两种狂犬病毒抗体检测试剂盒(试剂盒A、B)进行检测,统计血清中狂犬病毒Ig G抗体的水平,计算阳转率并比较差异。结果使用试剂盒A检测接种人用狂犬病疫苗(地鼠肾细胞)者血清样本的阳转率为91.7%,接种冻干人用狂犬病疫苗(Vero细胞)者血清样本的阳转率为51.0%;使用试剂盒B检测接种人用狂犬病疫苗(地鼠肾细胞)者血清样本的阳转率为100.0%,接种冻干人用狂犬病疫苗(Vero细胞)者血清样本的阳转率为74.5%。使用试剂盒B检测接种人用狂犬病疫苗(地鼠肾细胞)者血清样本的阳转率比试剂盒A高8.3%,使用试剂盒B检测接种冻干人用狂犬病疫苗(Vero细胞)者血清样本的阳转率比试剂盒A高23.5%。结论两种不同试剂盒上检测的抗体阳转率都反映出人用狂犬病疫苗(地鼠肾细胞)比冻干人用狂犬病疫苗(Vero细胞)的免疫效果好;使用两种不同试剂盒检测抗体阳转率的差异均具有统计学意义。
Objective To understand the effect of immunization with rabies vaccines for human use before exposure and to compare the difference in seroconversion rate for antibody against rabies virus between 2 different detection kits. Methods A total of 172 staff members were inoculated PHK cell( hamster-kidney-cell) rabies vaccines and Vero-cell rabies vaccines,respectively,which were detected Ig G antibody level in serum by 2 kinds of antibody detection kits( A and B) against rabies virus,and seroconversion rate were evaluated and the difference compared. Results The detected seroconversion rate was 91.7% for staff members inoculated PHK cell rabies vaccine,the same rate was 51.0% for staff members inoculated Vero-cell rabies vaccine by both using kit A. The detected seroconversion rate was 100% for staff members inoculated PHK cell rabies vaccine,the same rate was 74.5% for staff members inoculated Vero-cell rabies vaccine by both using kit B.The seroconversion rate was 8.3% higher by using kit B than kit A for staff members inoculated PHK cell rabies vaccine,the seroconversion rate was 23.5% higher by using kit B than kit A for staff members inoculated Vero-cell rabies vaccine. Conclusion The detected seroconversion rates showed that PHK rabies vaccine was better than the Vero-cell rabies vaccine.There were significant differences in detection of antibody seroconversion rate by both of detection kits.
引文
[1]俞永新,朱家鸿,徐葛林,等.狂犬病和狂犬病疫苗[M].2版.北京:中国医药科技出版社,2009.
[2]中国疾病预防控制中心.狂犬病预防控制技术指南(2016版)[J].中国病毒病杂志,2016,6(03):161-188.
[3]黄学勇,李幸乐,张白帆,等.人抗狂犬病病毒Ig G抗体3种检测系统的可比性研究[J].中国卫生检验杂志,2015,25(8):1172-1174.
[4]王伟伟,王远征,张国强,等.狂犬病病毒抗体竞争ELISA检测方法的建立及初步应用[J].中国生物制品学杂志,2011,24(11):1355-1359.
[5]董关木,郑海发,刘增顺,等.我国纯化狂犬病疫苗的临床反应及效果评价[J].中国生物制品学杂志,2002,15(5):312-314.
[6]周志军,尹斌,朱华松,等.ELISA抗体检测试剂盒在狂犬病毒特免血浆筛选中的初步应用[J].微生物学免疫学进展,2005,33(2):45-48.
[7]苏军英,陶小润,孙承梅,等.人用狂犬病疫苗免疫抗体检测方法的比较[J].中国生物制品学杂志,1999,12(4):236-237.